VIDEO: ‘Thrilling’ interventions coming for RSV

November 20, 2022

3 min watch

Supply:

Healio Interview

Disclosures:
Williams reviews serving on an unbiased information monitoring committee for GlaxoSmithKline and a scientific advisory board for Quidel.


NEW YORK — On this video filmed on the Infectious Illnesses in Kids Symposium, John V. Williams, MD, describes a number of interventions in improvement towards respiratory syncytial virus, which is at present surging in the US.

Based on Williams, these embrace newer, longer lasting monoclonal antibodies and multiple vaccine candidates in late-stage improvement.

Williams, who’s the division chief of pediatric infectious ailments on the UPMC Kids’s Hospital of Pittsburgh and director of the Institute for An infection, Irritation and Immunity in Kids (i4Kids), mentioned it’s “possible” there can be licensed RSV vaccines for older adults and pregnant individuals “throughout the subsequent 12 months or so.”

“That is actually thrilling for us as pediatricians as a result of we now have actually lacked instruments towards RSV for far too long,” Williams mentioned.

References:

Williams JV. Keynote presentation: Preview of coming points of interest: Preventions for RSV. Introduced at: Infectious Illnesses in Kids Symposium; Nov. 19-20, 2022; New York (hybrid assembly).

Share

Leave a Reply